Get audit-ready real-world data faster.
Real-world data makes models better, and privacy risk is what slows acquisition. Regulated datasets sit in procurement queues for months while legal and privacy teams assess exposure. Integral compresses that timeline from months to days.
The data-velocity problem
Training and evaluation pipelines need diverse, representative real-world data. But every regulated dataset triggers a privacy review cycle: legal assessment, vendor risk questionnaires, procurement back-and-forth, and board-level sign-off. Each cycle takes weeks or months. By the time the data arrives, the window may have closed.
The bottleneck is not the data. It is the unresolved privacy risk attached to the data. Integral resolves that risk with independent risk assessment, signal-preserving privacy engineering, and documentation that satisfies procurement on the first pass.
What Integral delivers
Accelerate acquisition
Independent risk assessment compresses the privacy review from months to days. Data reaches your pipeline while it is still relevant to the research objective.
Unlock enterprise procurement
Buyer procurement teams want defensibility documentation before they approve a dataset. Integral assesses the data, engineers remediation, verifies utility, and produces the evidence package they require.
Audit-ready posture
Every dataset ships with documentation scoped to the use case, the recipient, and the regulatory context. Continuous re-assessment keeps the posture current as data evolves.
How it works
Scope the use case and data
Integral maps the dataset, the intended training or evaluation objective, recipients, and regulatory context.
Assess and determine
Qualified statistical experts assess re-identification risk and deliver a signed, defensible opinion scoped to the engagement.
Signal-preserving engineering
Privacy remediation is calibrated to the analytical objective. Utility metrics document what the data retains after engineering.
Deliver with documentation
Audit-ready data ships with the determination, methodology provenance, utility report, and a re-assessment schedule.
What teams say
“By combining our data privacy infrastructure with Integral's privacy assessment technologies, we delivered a tailored solution that met our client's needs faster and more cost-effectively than alternatives. We look forward to supporting more clients in responsibly harnessing sensitive data for impactful LLM applications.”
Frequently asked questions
What types of data does this apply to?
Any regulated dataset where re-identification risk must be assessed: clinical, claims, genomic, consumer health, financial, and other sensitive data types.
Does Integral work with data we have already licensed?
Yes. Integral can assess and document datasets you already hold, improving your defensibility posture for existing and future uses.
What makes Integral's risk assessment different from other de-identification methods?
Integral delivers a signed, scoped opinion from qualified statistical experts on re-identification risk. For HIPAA-covered data, this takes the form of an Expert Determination — the highest standard of defensibility. For other regulated data, we provide equivalent independent assessments with documentation that procurement and regulatory teams trust.
Can Integral deploy in our environment?
Yes. Integral supports cloud, VPC, on-prem, and air-gapped deployment. Data does not have to leave your infrastructure.
